Genprex, Inc.GNPXNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank26
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P26
Within normal range
vs 3Y Ago
-1.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -12.27% |
| Q2 2025 | -1.59% |
| Q1 2025 | -10.52% |
| Q4 2024 | 2.99% |
| Q3 2024 | 65.38% |
| Q2 2024 | -49.10% |
| Q1 2024 | -11.81% |
| Q4 2023 | -19.57% |
| Q3 2023 | 16.08% |
| Q2 2023 | -25.11% |
| Q1 2023 | 60.00% |
| Q4 2022 | 5.10% |
| Q3 2022 | 7.89% |
| Q2 2022 | 43.46% |
| Q1 2022 | -41.38% |
| Q4 2021 | 143.04% |
| Q3 2021 | -6.18% |
| Q2 2021 | -29.64% |
| Q1 2021 | -6.48% |
| Q4 2020 | 71.80% |
| Q3 2020 | -37.37% |
| Q2 2020 | 45.86% |
| Q1 2020 | 201.87% |
| Q4 2019 | 4.76% |
| Q3 2019 | -6.91% |
| Q2 2019 | -1.18% |
| Q1 2019 | 60.19% |
| Q4 2018 | -35.23% |
| Q3 2018 | 333.47% |
| Q2 2018 | 118.84% |
| Q1 2018 | -15.48% |
| Q4 2017 | 10.01% |
| Q3 2017 | -47.12% |
| Q2 2017 | 53.56% |
| Q1 2017 | -47.14% |
| Q4 2016 | 43.87% |
| Q3 2016 | 12.70% |
| Q2 2016 | 42.75% |
| Q1 2016 | 0.00% |